Adults Experiencing Higher Level of Anxiety Today Due to Ongoing Pandemic, Inflation, and War

Software Advice research on worry burnout reveals a third of adults and a quarter of children have started therapy since the pandemic, leading to a surge in demand for mental health professionals. AUSTIN, Texas–(BUSINESS WIRE)–Worry burnout is manifesting across the country as the ongoing pandemic collides with the Russia-Ukraine war and skyrocketing inflation. To get … [Read more…]

Nature’s Toolbox, Inc. to Participate in the 2022 BIO International Convention

RIO RANCHO, N.M.–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx), a life sciences company enabling novel RNA product development, today announced that several of its executives will attend the Biotechnology Innovation Organization (BIO) International Convention taking place at the San Diego Convention Center from Monday, June 13 – Thursday, June 16, 2022. NTx is a leader in producing … [Read more…]

FOLX Health Launches Enterprise Solution, Enabling Employers to Offer Health and Wellness Benefits to their LGBTQIA+ Workforce

The Queer and Trans Healthcare Provider is Also Announcing a new Chief Commercial Officer and Launching a Peer-to-Peer Platform in Partnership with Trans NCAA Swimmer Schuyler Bailar BOSTON–(BUSINESS WIRE)–FOLX Health, the first digital healthcare service provider designed by and for the medical needs of the LGBTQIA+ community, today launched an enterprise solution that enables employers … [Read more…]

Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the Jefferies Global Healthcare Conference. Dr. Brady’s conversation with Kelly Shi, Ph.D., Senior … [Read more…]

Lyndra Therapeutics Doses First Clinical Trial Participant in Study of Oral Biweekly Ivermectin (LYN-163) as a Tool in the Fight to Eradicate Malaria

Trial marks first-ever clinical study delivering two weeks of drug in a single oral dose Funded by a grant from the Bill & Melinda Gates Foundation, Lyndra answers World Health Organization’s call to investigate ivermectin as a new malaria eradication strategy WATERTOWN, Mass.–(BUSINESS WIRE)–Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a … [Read more…]

FDA Clears Thermo Scientific EliA RNA Pol III and EliA Rib-P Tests for Use in U.S.

New blood tests aid in diagnosing systemic sclerosis and systemic lupus erythematosus PORTAGE, Mich.–(BUSINESS WIRE)–Thermo Scientific EliA RNA Pol III and EliA Rib-P tests have been cleared by the U.S. Food & Drug Administration (FDA) for aiding in the diagnosis of Systemic Sclerosis (SSc; scleroderma) and Systemic Lupus Erythematosus (SLE). With these new tests, the … [Read more…]

LifeWorks leveraging power of peer support with launch of LifeWorks Community

New service connects people online to reduce isolation and offer mental health support TORONTO–(BUSINESS WIRE)–LifeWorks, a world leader in providing in-person and digital solutions that support the mental health and total wellbeing of individuals, has launched LifeWorks Community worldwide – including in Canada, the United States, the United Kingdom, Australia and beyond. The program gives … [Read more…]

OBIO’s Early Adopter Health Network (EAHN™) and the City of Kawartha Lakes Family Health Team Launch a Project with AI Platform Goji Voice to Improve Patient Experience

TORONTO–(BUSINESS WIRE)–The Ontario Bioscience Innovation Organization (OBIO®) and the City of Kawartha Lakes Family Health Team (CKL FHT) are launching a project in Ontario through OBIO’s Early Adopter Health Network (EAHN™) to improve the patient and provider experience, and enhance health outcomes via Goji Technology Systems’ innovative artificial intelligence (AI) virtual assistant platform, Goji Voice. … [Read more…]

Concert Pharmaceuticals to Participate in Fireside Chat at The JMP Securities Life Sciences Conference

LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #AlopeciaAreata—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate in a fireside chat at The JMP Securities Life Sciences Conference on June 16, 2022 at 1:00 p.m. ET in New York, NY. A webcast of the JMP fireside chat may be accessed in the Investors section of the Company’s website … [Read more…]

Ferring Announces New Collaboration for Development of Olamkicept

Strategic collaboration to further develop olamkicept highlights Ferring’s continued commitment to innovation in gastroenterology and inflammatory bowel disease. Olamkicept is the first and only clinical stage selective interleukin-6 (IL-6) inhibitor that works through the trans-signaling mechanism. IL-6 is associated with a number of inflammatory conditions, such as inflammatory bowel disease (IBD). SAINT-PREX, Switzerland–(BUSINESS WIRE)–#Ferring–Ferring Pharmaceuticals … [Read more…]